Keywords: sales, leap, boosts, sanofi-synthelabo, french, drugmaker, reported
53.7% US sales leap boosts Sanofi-Synthelabo
Article | 27 January 2003
French drugmaker Sanofi-Synthelabo has reported 2002 revenues in linewith expectations, with consolidated turnover of 7.45 billion euros ($7.94 billion), up 12.8%, and developed sales ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
